Progyny (PGNY) Share-based Compensation (2018 - 2026)
Progyny's (PGNY) quarterly Share-based Compensation came in at $20.5 million in Q2 2026, down 36.76% year-over-year from $32.4 million in Q2 2025, and up 3.84% quarter-over-quarter from $19.7 million in Q1 2026.
Analysis
Progyny (PGNY) Share-based Compensation (2018 - 2026) Analysis & Trends
Progyny (PGNY) has reported Share-based Compensation for 9 consecutive years, with $20.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation fell 36.76% year-over-year to $20.5 million in Q2 2026; TTM through Jun 2026 was $107.2 million, a 16.88% decrease from a year earlier, with the FY2025 full-year figure at $131.9 million, up 2.92% from the prior year.
- Share-based Compensation was $20.5 million for Q2 2026 at Progyny, up from $19.7 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $34.8 million in Q4 2025 and troughed at $19.7 million in Q1 2026.
- A 5-year average of $29.1 million and a median of $31.0 million in 2024 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation surged 386.69% in 2022 and tumbled 39.34% in 2026, its largest moves.
- Over 5 years, Share-based Compensation stood at $29.3 million in 2022, then declined by 1.7% to $28.8 million in 2023, then advanced by 7.15% to $30.9 million in 2024, then advanced by 12.77% to $34.8 million in 2025, then tumbled by 41.15% to $20.5 million in 2026.
- The last three Share-based Compensation figures came in at $20.5 million (Q2 2026), $19.7 million (Q1 2026), and $34.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.76 Bn | 12.63 Bn | 1.16 Bn | 659,000.00 |
| 2 | RadNet | 5.98 Bn | 5.55 Bn | 88.08 Mn | 10.54 Mn |
| 3 | Concentra Group Holdings Parent | 4.52 Bn | 4.39 Bn | 192.10 Mn | 4.13 Mn |
| 4 | Privia Health | 2.51 Bn | 2.15 Bn | - | 19.40 Mn |
| 5 | Pediatrix Medical | 2.11 Bn | 1.70 Bn | - | 7.10 Mn |
| 6 | Progyny | 2.10 Bn | 1.86 Bn | 89.30 Mn | 20.48 Mn |
| 7 | Fresenius Medical Care AG | 2.07 Bn | 1.37 Bn | 1.52 Bn | -65.64 Mn |
| 8 | Surgery Partners | 1.73 Bn | 2.95 Bn | 622.10 Mn | 3.80 Mn |
| 9 | U S Physical Therapy | 1.23 Bn | 1.52 Bn | 41.94 Mn | 2.40 Mn |
| 10 | Starling Oncology | 699.26 Mn | 658.17 Mn | 27.17 Mn | 1.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.48 Mn |
| Mar 31, 2026 | 19.72 Mn |
| Dec 31, 2025 | 34.80 Mn |
| Sep 30, 2025 | 32.17 Mn |
| Jun 30, 2025 | 32.38 Mn |
| Mar 31, 2025 | 32.51 Mn |
| Dec 31, 2024 | 30.86 Mn |
| Sep 30, 2024 | 33.18 Mn |
| Jun 30, 2024 | 33.04 Mn |
| Mar 31, 2024 | 31.05 Mn |
| Dec 31, 2023 | 28.80 Mn |
| Sep 30, 2023 | 31.25 Mn |
| Jun 30, 2023 | 31.75 Mn |
| Mar 31, 2023 | 30.81 Mn |
| Dec 31, 2022 | 29.30 Mn |
| Sep 30, 2022 | 23.30 Mn |
| Jun 30, 2022 | 23.65 Mn |
| Mar 31, 2022 | 24.50 Mn |
| Dec 31, 2021 | 15.01 Mn |
| Sep 30, 2021 | 7.15 Mn |